Loading ...

A Phase 2a Trial Of Teplizumab And RN168 In Patients With New Onset Type 1 Diabetes Mellitus

(

)

ITN Protocol #:

ITN083AI

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Withdrawn

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Study Personnel:

Protocol Chair

Kevan Herold, MD kevan.herold@yale.edu

Work:

203-785-6507

Admin Links

Shortcuts

ITN Documents

Links